rs184344717
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_022455.5(NSD1):c.4966+43G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000591 in 1,184,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000040 ( 0 hom. )
Consequence
NSD1
NM_022455.5 intron
NM_022455.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.33
Publications
0 publications found
Genes affected
NSD1 (HGNC:14234): (nuclear receptor binding SET domain protein 1) This gene encodes a protein containing a SET domain, 2 LXXLL motifs, 3 nuclear translocation signals (NLSs), 4 plant homeodomain (PHD) finger regions, and a proline-rich region. The encoded protein enhances androgen receptor (AR) transactivation, and this enhancement can be increased further in the presence of other androgen receptor associated coregulators. This protein may act as a nucleus-localized, basic transcriptional factor and also as a bifunctional transcriptional regulator. Mutations of this gene have been associated with Sotos syndrome and Weaver syndrome. One version of childhood acute myeloid leukemia is the result of a cryptic translocation with the breakpoints occurring within nuclear receptor-binding Su-var, enhancer of zeste, and trithorax domain protein 1 on chromosome 5 and nucleoporin, 98-kd on chromosome 11. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Sep 2018]
NSD1 Gene-Disease associations (from GenCC):
- Beckwith-Wiedemann syndrome due to NSD1 mutationInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Sotos syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
- Sotos syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 5-177257194-G-A is Benign according to our data. Variant chr5-177257194-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 261589.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000195 (29/148406) while in subpopulation AFR AF = 0.000715 (29/40548). AF 95% confidence interval is 0.000511. There are 0 homozygotes in GnomAd4. There are 18 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 29 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000189 AC: 28AN: 148336Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
28
AN:
148336
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000798 AC: 18AN: 225676 AF XY: 0.0000495 show subpopulations
GnomAD2 exomes
AF:
AC:
18
AN:
225676
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000396 AC: 41AN: 1035952Hom.: 0 Cov.: 19 AF XY: 0.0000378 AC XY: 20AN XY: 528930 show subpopulations
GnomAD4 exome
AF:
AC:
41
AN:
1035952
Hom.:
Cov.:
19
AF XY:
AC XY:
20
AN XY:
528930
show subpopulations
African (AFR)
AF:
AC:
23
AN:
26080
American (AMR)
AF:
AC:
5
AN:
41334
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
22982
East Asian (EAS)
AF:
AC:
0
AN:
36192
South Asian (SAS)
AF:
AC:
2
AN:
74674
European-Finnish (FIN)
AF:
AC:
0
AN:
50626
Middle Eastern (MID)
AF:
AC:
1
AN:
4896
European-Non Finnish (NFE)
AF:
AC:
4
AN:
733160
Other (OTH)
AF:
AC:
6
AN:
46008
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000195 AC: 29AN: 148406Hom.: 0 Cov.: 31 AF XY: 0.000249 AC XY: 18AN XY: 72264 show subpopulations
GnomAD4 genome
AF:
AC:
29
AN:
148406
Hom.:
Cov.:
31
AF XY:
AC XY:
18
AN XY:
72264
show subpopulations
African (AFR)
AF:
AC:
29
AN:
40548
American (AMR)
AF:
AC:
0
AN:
14914
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3418
East Asian (EAS)
AF:
AC:
0
AN:
5008
South Asian (SAS)
AF:
AC:
0
AN:
4660
European-Finnish (FIN)
AF:
AC:
0
AN:
9666
Middle Eastern (MID)
AF:
AC:
0
AN:
284
European-Non Finnish (NFE)
AF:
AC:
0
AN:
66958
Other (OTH)
AF:
AC:
0
AN:
2052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.